STAT | Reporting from the frontiers of health and medicine 中文 关注 STAT+：治疗罕见疾病天使综合征的 Ultragenyx 药物在晚期试验中失败” Ultragenyx 表示，其针对罕见疾病安格曼综合征（Angelman syndrome）的实验性疗法在 III 期临床试验中，与安慰剂相比未显示出任何益处。 STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial statnews.com STAT | Reporting from the frontiers of health and medicine 中文 RSS thenote.app
